July policy updates

Turn on more accessible mode

Turn off more accessible mode

Skip Ribbon Commands

Skip to main content

Turn off Animations

Turn on Animations

Provider News Center

Share

Focus on Content

Billing & Reimbursement

Health and Wellness

Quality Management

TitleWeb
July policy updates

August 5, 2022

In July, AmeriHealth updated several policies. Published updates include:

08.00.85m: Tocilizumab (Actemra^®) for Intravenous Infusion. Effective date: July 18, 2022
08.01.94: Nivolumab and relatlimab-rmbw (Opdualag™). Effective date: July 18, 2022

To view the latest medical and claim payment policy bulletins, visit the Medical and Claim Payment Policy Portal.

For important policy information related to COVID-19, visit the News & Announcements section of the portal.

Quick Links

Behavioral Health

Behavioral Health FAQ

Platform Transition

Provider Data Maintenance

Frequently Asked Questions

Manuals

Medical and Claim Payment Policy Portal

Opioid Awareness

Provider eBusiness Inquiry form

Services that require precertification

Utilization Management

Archives

Partners in Health Update past edition PDFs

Cumulative Index

ICD-10 Transition

System and Process Changes Archive

Exclusive National Lab Provider (NJ Only)

This content was prepared for the Provider News Center and may not be reproduced in any way without the express written permission of AmeriHealth, AmeriHealth HMO, Inc., AmeriHealth Insurance Company of New Jersey.

© 2023 AmeriHealth Site Map Anti-Fraud Privacy Policy Legal Disclaimer